Copyright
©The Author(s) 2020.
World J Gastroenterol. Jul 7, 2020; 26(25): 3673-3685
Published online Jul 7, 2020. doi: 10.3748/wjg.v26.i25.3673
Published online Jul 7, 2020. doi: 10.3748/wjg.v26.i25.3673
Table 2 Infection rates of type I and type II Helicobacter pylori in stepwise chronic gastric diseases
Groups | Total | H. pylori (+) | H. pylori (-) | Type IH. pylori (+) | Type IIH. pylori (+) |
NAG | 213 | 140 (65.7) | 73 (34.3) | 95 (67.9)a | 45 (32.1) |
NAGE | 96 | 75 (78.1)c | 21 (21.9) | 47 (62.7)a | 28 (37.3) |
PU | 94 | 85 (90.4)c | 9 (9.6) | 66 (77.6)ae | 19 (22.4) |
CAG | 77 | 64 (83.1)c | 13 (16.9) | 51 (79.7)ae | 13 (20.3) |
GC | 43 | 38 (88.4)c | 5 (11.6) | 32 (84.2)ae | 6 (15.8) |
Total | 523 | 402 (76.9) | 121 (23.1) | 291 (72.4) | 111 (27.6) |
- Citation: Yuan L, Zhao JB, Zhou YL, Qi YB, Guo QY, Zhang HH, Khan MN, Lan L, Jia CH, Zhang YR, Ding SZ. Type I and type II Helicobacter pylori infection status and their impact on gastrin and pepsinogen level in a gastric cancer prevalent area. World J Gastroenterol 2020; 26(25): 3673-3685
- URL: https://www.wjgnet.com/1007-9327/full/v26/i25/3673.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i25.3673